Our collaborative research team has received a new four-year NIH Multi-PI R01 to investigate how tobacco smoke-induced metabolic reprogramming and PRMT5 lactylation promote fibroblast activation and pulmonary fibrosis. The project will define the molecular mechanisms linking protein lactylation, epigenetic regulation, and fibrotic remodeling and evaluate PRMT5 as a potential therapeutic target.